Intelligence Platform
Patents
Browse 738 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9233940
Cyclic peptidomimetic compounds as immunomodulators
granted patentUS 9227995
Peptides
granted patentUS 9221838
Inhibitors of AKT activity
granted patentUS 9221840
Treating protein folding disorders with small molecule CFTR correctors
granted patentUS 9221843
Heteroaryl inhibitors of PDE4
granted patentUS 9180161
CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorder
granted patentUS 9173886
Antiviral compounds and methods of use thereof
granted patentUS 9169280
Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic use
granted patentUS 9156853
AKT inhibitor compounds for treatment of cancer
granted patentUS 9138386
Dental whitening compositions
granted patentUS 9133127
Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions,
granted patentUS 9096642
Therapeutic compounds for immunomodulation
granted patentUS 9096608
Pharmaceutically active pyrazolo-triazine derivatives
granted patentUS 9062075
Tetrahydropyridine derivatives as FabI inhibitors
granted patentUS 9062002
Substituted pyridine derivatives as FabI inhibitors
granted patentUS 9062007
Cyclic amide BACE-1 inhibitors having a benzamide substituent
granted patentUS 9056847
Activity based probes (ABPs) interacting with glycosidases
granted patentUS 9051312
Methods of treating dyskinesia and related disorders
granted patentUS 9044442
Peptidomimetic compounds as immunomodulators
granted patentUS 9034923
Methods for the treatment of senile dementia of the alzheimer's type
granted patentUS 8999982
Pharmaceutically active compounds as Axl inhibitors
granted patentUS 8993623
Method for lowering cholesterol
granted patentUS 8986005
Strip for transferring a therapeutic composition to a tooth
granted patentUS 8981057
B-cell stimulating fusion proteins of an antigen with BAFF or APRIL
granted